Literature DB >> 10203278

Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin.

J Califano1, W H Westra, W Koch, G Meininger, A Reed, L Yip, J O Boyle, F Lonardo, D Sidransky.   

Abstract

BACKGROUND: Unknown primary head and neck squamous cell carcinoma (HNSCC) presents as a cervical lymph node metastasis without identification of the primary tumor, despite thorough diagnostic work-up that includes physical examination, computed tomography, esophagoscopy, laryngoscopy, bronchoscopy, and multiple surveillance biopsies. We investigated whether the site of origin of the primary tumor could be localized in the upper aerodigestive tract mucosa by detection of genetic alterations identical to those found in metastatic lesions.
METHODS: Microsatellite analysis was performed on metastatic tumors obtained from 18 patients with unknown primary HNSCC. Histologically benign surveillance biopsy specimens were also analyzed. Patients were followed up to 13 years with continuing surveillance for primary mucosal tumors. Most patients were treated with neck dissection followed by radiation therapy to the affected neck and ipsilateral Waldeyer's ring.
RESULTS: In 10 (55%) of the 18 patients, at least one histopathologically benign mucosal biopsy specimen from defined anatomic sites (i.e., most likely sites for an occult primary tumor) demonstrated a pattern of genetic alterations identical to that present in cervical lymph node metastases. One patient harboring genetic alterations in the base of the tongue and two patients harboring genetic alterations in a tonsillar fossa subsequently developed HNSCC in the identical or adjacent mucosal region; all three of the primary head and neck mucosal tumors that eventually appeared between 1 and 13 years later in these patients had genetic changes identical to those in the benign mucosal biopsy specimens and in the metastatic lymph nodes.
CONCLUSIONS: These data support the hypothesis that histopathologically benign mucosa of the upper aerodigestive tract may harbor foci of clonal, preneoplastic cells that are genetically related to metastatic HNSCC and that such mucosal sites are the sites of origin of unknown primary HNSCC. Microsatellite analysis may represent a clinically useful tool for determining such sites.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203278     DOI: 10.1093/jnci/91.7.599

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  27 in total

1.  Clonal origin and expansions in neoplasms: biologic and technical aspects must be considered together.

Authors:  Lucia Pozo-Garcia; Salvador J Diaz-Cano
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

Review 2.  Progress in refining the clinical management of cancer of unknown primary in the molecular era.

Authors:  Elie Rassy; Nicholas Pavlidis
Journal:  Nat Rev Clin Oncol       Date:  2020-04-29       Impact factor: 66.675

3.  Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomas.

Authors:  I Cruz; P J F Snijders; V Van Houten; M Vosjan; I Van der Waal; C J L M Meijer
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

4.  Clinicopathological characteristics of carcinoma from unknown primary in cervical lymph nodes.

Authors:  Daniel Weiss; Mario Koopmann; Markus Stenner; Eleftherios Savvas; Claudia Rudack
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-17       Impact factor: 2.503

Review 5.  Diagnosis and management of neck metastases from an unknown primary.

Authors:  L Calabrese; B A Jereczek-Fossa; J Jassem; A Rocca; R Bruschini; R Orecchia; F Chiesa
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-02       Impact factor: 2.124

6.  Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening.

Authors:  A K El-Naggar; L Mao; G Staerkel; M M Coombes; S L Tucker; M A Luna; G L Clayman; S Lippman; H Goepfert
Journal:  J Mol Diagn       Date:  2001-11       Impact factor: 5.568

7.  An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.

Authors:  Charles M Rudin; Ezra E W Cohen; Vassiliki A Papadimitrakopoulou; Sol Silverman; Wendy Recant; Adel K El-Naggar; Kirsten Stenson; Scott M Lippman; Waun Ki Hong; Everett E Vokes
Journal:  J Clin Oncol       Date:  2003-11-03       Impact factor: 44.544

8.  [Cancer of unknown primary. Epidemiology and pathogenesis].

Authors:  H Löffler; K Neben; A Krämer
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

9.  Metastases in the Absence of a Primary Tumor: Advances in the Diagnosis and Treatment of CUP Syndrome.

Authors:  Kai Neben; Gerdt Hübner; Gunnar Folprecht; Dirk Jäger; Alwin Krämer
Journal:  Dtsch Arztebl Int       Date:  2008-10-24       Impact factor: 5.594

10.  Predictive Role of p53 Protein as a Single Marker or Associated to Ki67 Antigen in Oral Carcinogenesis.

Authors:  L Montebugnoli; L Felicetti; D B Gissi; F Cervellati; D Servidio; C Marchetti; C Prati; F Flamminio; M P Foschini
Journal:  Open Dent J       Date:  2008-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.